CTLA4 and cancer: In addition, our pan-cancer analysis revealed a negative correlation between p62 and PD-1 in four cancers (BRCA, LIHC, PRAD, THCA), and with CTLA-4 in eight cancers (KIRC, ESCA, READ, COAD, PAAD, BRCA, PRAD, THCA).